HOME >> BIOLOGY >> NEWS
Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine

CALGARY, AB, --- April 17, 2007 - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announces that a poster by Dr. Maureen E. Lane et al. of Cornell University, New York, entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented today at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, CA. The meeting runs from April 14-18, 2007.

The researchers found that treatment of human colon cancer cell lines with the combination of REOLYSIN and gemcitabine resulted in both in vitro and in vivo synergy. There was no toxicity associated with the combined treatment. Tumours treated with the combination were significantly smaller (by area and weight) than tumours in control groups or tumours treated with either agent alone. The researchers concluded that the synergistic combination of REOLYSIN and gemcitabine is a promising therapeutic regimen for study in clinical trials.

"It is rare to see the virtual elimination of tumours as well as the long-lasting therapeutic effect that we have observed from this study," said Dr. Brad Thompson, President and CEO of Oncolytics. "We are very encouraged by these results and look forward to testing this particular treatment combination in our upcoming human systemic administration trial in the U.K."


'"/>

Contact: Cathy Ward
cathy.ward@oncolytics.ca
403-670-7370
Oncolytics Biotech Inc.
17-Apr-2007


Page: 1

Related biology news :

1. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial
2. Biotech breakthrough could end biodiesels glycerin glut
3. How the Biotech Revolution Is Changing the Way We Fight Disease
4. Rutgers: GM/GMO/Biotech crop containment strategy
5. Ronald Cape to receive 2007 Biotechnology Heritage Award
6. Biotechnology Study Center honors Joan V. Ruderman, Salvador Moncada and Charles N. Serhan
7. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
8. Advances in Optics for Biotechnology, Medicine and Surgery
9. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
10. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
11. Biotech cotton provides same yield with fewer pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2019)... ... 2019 , ... uBiome, the leader in microbial genomics, announces ... Jackson Laboratory (JAX), to its Scientific Advisory Board. Joining the board of leading ... expertise in skin microbial interactions and probiotic treatments for skin and infectious diseases. ...
(Date:1/24/2019)... (PRWEB) , ... January 23, 2019 , ... ... that it has received a Notice of Allowance from the United States Patent ... filed by its affiliate company, DNA Medicine Institute (DMI). This application covers the ...
(Date:1/20/2019)... ... 2019 , ... uBiome, the leader in microbial genomics, has ... intelligence (AI) and a data-centric approach to decentralize medicine using blockchain to better ... will Crohn’s or other chronic medical conditions join a relevant study through the ...
Breaking Biology News(10 mins):
(Date:2/2/2019)... ... , ... Stay on top of current hot topics through free webinars presented ... webinars is free, so be sure to register today to save your place! Participate ... check out our upcoming webinars, or click below to learn more about each webinar: ...
(Date:1/30/2019)... , ... January 29, 2019 , ... K&R Negotiations announced ... expert at a special online event titled: Six Ways to Shorten the Sales ... time, February 13, 2019 on the BrightTALK network. , Negotiation expert Kresic will ...
(Date:1/30/2019)... ... January 30, 2019 , ... In 2016, Veronafiere and Vinitaly ... and give recognition to producers whose work focuses entirely on natural, organic and ... Verona, Italy, contemporaneously to the 5StarWines blind tasting organized from April 3rd to ...
(Date:1/24/2019)... , ... January 22, 2019 , ... ... each trial has its own set of assumptions, and RFP creation and management ... evaluating bids is like comparing apples to oranges. These challenges can ultimately lead ...
Breaking Biology Technology:
Cached News: